Continuous preperitoneal versus thoracic epidural analgesia in open pancreaticoduodenectomy: a randomised controlled trial
2024

Pain Management After Abdominal Surgery: Is Epidural Analgesia Still Effective?

Editorial Evidence: moderate

Author Information

Author(s): Dileep N. Lobo, Girish P. Joshi

Primary Institution: University of Nottingham

Hypothesis

Is continuous preperitoneal infusion of ropivacaine as effective as thoracic epidural analgesia for pain management after open pancreatoduodenectomy?

Conclusion

The study suggests that continuous wound infusion of ropivacaine may provide equivalent pain relief to thoracic epidural analgesia while reducing complications.

Supporting Evidence

  • Continuous epidural analgesia has been effective in only 60-70% of patients.
  • The study found no difference in mean pain scores on postoperative days 1 and 2.
  • Continuous wound infusion provided better pain relief and quality of recovery on postoperative day 3.
  • Postoperative hypotension was more frequent in the thoracic epidural group.

Takeaway

This study looks at two ways to help with pain after surgery. It found that one method works just as well as the other, but with fewer problems.

Methodology

The study compared continuous preperitoneal infusion of ropivacaine with thoracic epidural analgesia in patients undergoing open pancreatoduodenectomy.

Limitations

The study did not conform to optimal clinical practice, and the management of both groups may not have been ideal for pain control.

Digital Object Identifier (DOI)

10.1093/bjs/znae299

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication